Delivery Order SPE2DB20D2001-SPE2DB25FPMXS

Award Date 6/11/25
Potential Completion Date 6/12/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,609.51 firm fixed-price delivery order is for the supply of 4567528198 - DEXTROAMP-AMPHET ER 10 MG CAP 100S. The contract has an ultimate completion date of March 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,852.98, is a Delivery Order for the supply of 4568367035 - DEXTROAMP-AMPHET ER 20 MG CAP 100S. It is a Firm Fixed Price contract with a period of performance through May 28, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $1,722.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567458315 DEXTROAMP-AMPHET ER 10 MG CAP 100S, a pharmaceutical product. The contract is a delivery order with a firm fixed price and has an ultimate completion date of March 5, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a delivery order with a firm fixed price of $1,401.52 and a completion date of May 29, 2025. The award is for the supply of DEXTROAMP-AMPHET ER 20 MG CAP 100S, a pharmaceutical product, and is not a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $1,190.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB24D2100|SPE2DB25FBDRN) for the supply of 4567967859 DEXTROAMP-AMPHET ER 20 MG CAP 100S, with a firm fixed price and an ultimate completion date of April 21, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the...
This federal contract award is a delivery order valued at $1,988.40 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract, which does not have a set-aside designation, was awarded by the Defense Logistics Agency (DLA) on May 23, 2025 with an ultimate completion date of May 27, 2025. The contract provides for the delivery of 4568346823 ! DEXTROAMP-AMPHET ER 20 MG CAP 100S, a pharmaceutical product....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,152.99, is a delivery order for 4568569097 - DEXTROAMP-AMPHET ER 20 MG CAP 100S. The contract is a firm fixed-price, non-set-aside award with a completion date of June 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,191.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22D1202|SPE2DB25FUYU0) for the supply of 4568040534 - DEXTROAMP-AMPHET ER 10 MG CAP 100S, a pharmaceutical product. The contract has an ultimate completion date of April 28, 2025 and is a firm fixed-price arrangement. This contract is not associated with a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,025.98 Firm Fixed Price Delivery Order is for the supply of 4567684725 DEXTROAMP-AMPHET ER 20 MG CAP 100S, a prescription medication. The contract has an ultimate completion date of March 26, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $1,024.37, with a performance period ending on June 6, 2025. It was awarded by the Defense Logistics Agency, a defense agency, for the provision of 4568460740 ! DEXTROAMP-AMPHET ER 30 MG CAP 100S. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition....
  • SPE2DB20D2001
    Indefinite Delivery Contract
  • SPE2DB20D2001-SPE2DB25FPMXS
    Delivery Order

This federal contract award, valued at $1,112.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for DEXTROAMP-AMPHET ER 30 MG CAP 100S, with an ultimate completion date of June 12, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime contract, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. This specific delivery order is not designated as a set-aside contract.

Generated 9/10/25, 9:57 AM